Compare AU

Compare CURE vs. IBAL

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Industry & Region

Industry & Region


Country Exposure

CURE

IBAL

United States

97.17 %

47.38 %

Switzerland

1.51 %

1.58 %

United Kingdom of Great Britain and Northern Ireland

1.16 %

2.12 %

Ireland

0.16 %

0.10 %

Australia

36.02 %

Japan

3.94 %

Canada

1.70 %

France

1.39 %

Netherlands

1.07 %

Denmark

0.91 %

New Zealand

0.89 %

Germany

0.68 %

Sweden

0.55 %

Italy

0.39 %

Spain

0.26 %

Finland

0.23 %

Hong Kong

0.21 %

Singapore

0.21 %

Brazil

0.17 %

Norway

0.10 %

Belgium

0.07 %

Portugal

0.01 %

Austria

0.01 %

Israel

0.01 %


Industry Exposure

icon for key differences panel

Key differences

  • โ€ข

    CURE has a lower allocation (10.24 %) in the Other sector than IBAL (99.97 %).

  • โ€ข

    The most popular industries that CURE is exposed to are Health Care (100.00 %), and Other (10.24 %). Comparatively, IBAL is most exposed to Other (99.97 %), and Communication Services (0.03 %).

CURE

IBAL

Health Care

100.00 %

Other

10.24 %

99.97 %

Communication Services

0.03 %

Home